AstraZeneca said on Monday its Covid-19 vaccine could be as much as 90% effective, giving the world's fight against the global pandemic a new weapon, cheaper to make, easier to distribute and faster to scale-up than rivals.
Britain’s AstraZeneca said on Monday its vaccine for the novel coronavirus could be around 90% effective without any serious side effects, giving the world another important tool to halt the Covid-19 pandemic.
The head of an Indian company contracted to make AstraZeneca Plc's -19 vaccine said India could get access to it by January, as the country's total infections crossed nine million. Mass production of Russia's second vaccine could begin in 2021.
Serum Institute of India, the world's largest vaccine producer, said on Thursday it has made 40 million doses of AstraZeneca's potential Covid-19 vaccine, and would soon begin making Novavax's rival shot ...
The US government will pay as much as $1.19 billion to Eli Lilly and Co to secure nearly 1 million doses of its experimental Covid-19 antibody treatment, a drug similar to a treatment that US President Donald Trump received.
Spain would receive 31.6 million doses of the Covid-19 vaccine currently being developed by Britain's pharmaceutical giant AstraZeneca between December and June if it is ready, Health Minister Salvador Illa said on Tuesday.
The US Centers for Disease Control and Prevention (CDC) said on Wednesday that Covid-19 vaccines may not be initially recommended for children, when they become available.
Clinical trials of AstraZeneca and Oxford University's experimental Covid-19 vaccine have resumed in Japan, almost a month after being put on hold due to an illness of a British volunteer, while discussions with US authorities continue.
The European health regulator has started reviewing data on AstraZeneca and Oxford University's potential Covid-19 vaccine in real time, the first of such moves aimed at speeding up any approval process in the region for a vaccine.
Seven months after the emergence of the worst global health crisis in a century the race is on to find the medical equivalent of the Holy Grail -- a Covid-19 vaccine.
Positive news on initial trials of the University of Oxford's potential Covid-19 vaccine that has been licensed to AstraZeneca could be announced as soon as Thursday, ITV's political editor Robert Peston said, citing a source.
Brazil announced on Saturday that it had signed a $127 million agreement to start producing locally an experimental vaccine developed by AstraZeneca that has shown promise to fight the Covid-19 pandemic.